FDA seizes $6 million in products from Triad

The U.S. Marshals Service, at the request of the Food and Drug Administration, seized more than $6 million in products distributed by Triad Group at the company's facility in Hartland, the FDA said Wednesday. The drug products seized include povidone-iodine and benzalkonium chloride antiseptics, cough and cold products, nasal sprays, suppositories, medicated wipes, antifungal creams, hemorrhoidal wipes, in-process drug products, and raw materials. "We took this action to stop Triad from continuing to distribute products which may pose a risk to public health," Dara Corrigan, FDA associate commissioner for regulatory affairs, said in a statement. (MILWAUKEE JOURNAL SENTINEL, 4/7)